Cargando…
A Cost-Variation Analysis of Drugs Available in the Indian Market for the Management of Diabetic Nephropathy
Background Diabetic nephropathy is associated with polypharmacy and increased out-of-pocket expenditure for the patients. Multiple brands of each prescribed drug are available in the market. Hence, there is a need to evaluate the cost variation of the available brands of prescribed drugs. Methodolog...
Autores principales: | Advani, Manjari, Seetharaman, Rajmohan, Pawar, Manish, Naik, Bakul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635218/ https://www.ncbi.nlm.nih.gov/pubmed/36348866 http://dx.doi.org/10.7759/cureus.29942 |
Ejemplares similares
-
Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
por: Sharma, Kamal, et al.
Publicado: (2021) -
A Cross-sectional Retrospective Analysis of Glycemic Burden and Nephropathy in an Indian Population and Formulation of a New Plan Using eGFR/HbA1c Grid Formation
por: Roy, Sayak, et al.
Publicado: (2019) -
Role of Magnesium in Diabetic Nephropathy for Better Outcomes
por: Mamilla, Mahesh, et al.
Publicado: (2023) -
A Narrative Review of New Treatment Options for Diabetic Nephropathy
por: Pillai, Aadhira, et al.
Publicado: (2023) -
Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)